Block listing 6 Monthly Return

AI SummaryClose X

Shield Therapeutics plc has provided a six-monthly return for its share schemes, reporting a balance of 39,794 unallotted securities under the Retention Share Plan and 341,020 under the 2016 Company Share Option Plan, with no changes during the period from July 1, 2025, to December 31, 2025. The 2016 Long Term Incentive Plan also shows no activity, maintaining a balance of 24,273 unallotted securities. However, the Retention and Performance Share Plan saw an increase of 15,000,000 securities, with 6,137,791 issued, resulting in a closing balance of 11,733,071 unallotted securities.

Disclaimer*

UK 100

Latest directors dealings